Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
Edward M. Connor(ReveraGen BioPharma (United States)), James Balsley, Robert L. Jacobson(San Juan City Hospital), Mary Elkins(Burroughs Wellcome Fund), Mary Culnane(National Institute of Allergy and Infectious Diseases), William T. Shearer(Baylor College of Medicine), Richard D. Gelber(Harvard University), Robert W. Coombs(University of Namur), Pamela Stratton(National Institute of Neurological Disorders and Stroke), Jack Moye(National Institutes of Health), Russell VanDyke(San Juan City Hospital), Mohammed Bey(San Juan City Hospital), Rhoda Sperling(MDS Associates (United States)), Eleanor Jiménez(University of Miami), Jean-François Delfraissy(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Brigitte Bazin(Agence Nationale de Recherches sur le Sida et les Hépatites Virales), Mary Jo O’Sullivan(University at Buffalo, State University of New York), P.N. Kiselev(Boston University), Gwendolyn B. Scott, Edward H. O'Neill(University of Miami)
Cited by 3,738
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k